FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2038593826> ?p ?o ?g. }

• W2038593826 endingPage "105" @default.
• W2038593826 startingPage "99" @default.
• W2038593826 abstract "Background Everyday life demands continuous flexibility in thought and behavior. We examined whether individual differences in dopamine function are related to variability in the effects of amphetamine on one aspect of flexibility: task switching. Methods Forty healthy human participants performed a task-switching paradigm following placebo and oral amphetamine administration. [18F]fallypride was used to measure D2/D3 baseline receptor availability and amphetamine-stimulated dopamine release. Results The majority of the participants showed amphetamine-induced benefits through reductions in switch costs. However, such benefits were variable. Individuals with higher baseline thalamic and cortical receptor availability and striatal dopamine release showed greater reductions in switch costs following amphetamine than individuals with lower levels. The relationship between dopamine receptors and stimulant-enhanced flexibility was partially mediated by striatal dopamine release. Conclusions These data indicate that the impact of the psychostimulant on cognitive flexibility is influenced by the status of dopamine within a thalamocorticostriatal network. Beyond demonstrating a link between this dopaminergic network and the enhancement in task switching, these neural measures accounted for unique variance in predicting the psychostimulant-induced cognitive enhancement. These results suggest that there may be measurable aspects of variability in the dopamine system that predispose certain individuals to benefit from and hence use psychostimulants for cognitive enhancement. Everyday life demands continuous flexibility in thought and behavior. We examined whether individual differences in dopamine function are related to variability in the effects of amphetamine on one aspect of flexibility: task switching. Forty healthy human participants performed a task-switching paradigm following placebo and oral amphetamine administration. [18F]fallypride was used to measure D2/D3 baseline receptor availability and amphetamine-stimulated dopamine release. The majority of the participants showed amphetamine-induced benefits through reductions in switch costs. However, such benefits were variable. Individuals with higher baseline thalamic and cortical receptor availability and striatal dopamine release showed greater reductions in switch costs following amphetamine than individuals with lower levels. The relationship between dopamine receptors and stimulant-enhanced flexibility was partially mediated by striatal dopamine release. These data indicate that the impact of the psychostimulant on cognitive flexibility is influenced by the status of dopamine within a thalamocorticostriatal network. Beyond demonstrating a link between this dopaminergic network and the enhancement in task switching, these neural measures accounted for unique variance in predicting the psychostimulant-induced cognitive enhancement. These results suggest that there may be measurable aspects of variability in the dopamine system that predispose certain individuals to benefit from and hence use psychostimulants for cognitive enhancement." @default.
• W2038593826 created "2016-06-24" @default.
• W2038593826 creator A5003815693 @default.
• W2038593826 creator A5006125403 @default.
• W2038593826 creator A5017827035 @default.
• W2038593826 creator A5020143742 @default.
• W2038593826 creator A5024844325 @default.
• W2038593826 creator A5024948156 @default.
• W2038593826 creator A5036545204 @default.
• W2038593826 creator A5040205642 @default.
• W2038593826 creator A5042105567 @default.
• W2038593826 creator A5066655151 @default.
• W2038593826 creator A5081675173 @default.
• W2038593826 creator A5090326622 @default.
• W2038593826 date "2013-07-01" @default.
• W2038593826 modified "2023-09-23" @default.
• W2038593826 title "A Thalamocorticostriatal Dopamine Network for Psychostimulant-Enhanced Human Cognitive Flexibility" @default.
• W2038593826 cites W1938725568 @default.
• W2038593826 cites W1964320082 @default.
• W2038593826 cites W1969052084 @default.
• W2038593826 cites W1969635251 @default.
• W2038593826 cites W1973371295 @default.
• W2038593826 cites W1975078962 @default.
• W2038593826 cites W1978036977 @default.
• W2038593826 cites W1979384413 @default.
• W2038593826 cites W1979792701 @default.
• W2038593826 cites W1981091336 @default.
• W2038593826 cites W1984122101 @default.
• W2038593826 cites W1986105672 @default.
• W2038593826 cites W1989475654 @default.
• W2038593826 cites W1992615559 @default.
• W2038593826 cites W1999780060 @default.
• W2038593826 cites W2001099593 @default.
• W2038593826 cites W2002132239 @default.
• W2038593826 cites W2003244414 @default.
• W2038593826 cites W2005269174 @default.
• W2038593826 cites W2022520571 @default.
• W2038593826 cites W2039912069 @default.
• W2038593826 cites W2046230471 @default.
• W2038593826 cites W2048396168 @default.
• W2038593826 cites W2058548095 @default.
• W2038593826 cites W2066369089 @default.
• W2038593826 cites W2069126279 @default.
• W2038593826 cites W2071783141 @default.
• W2038593826 cites W2086683101 @default.
• W2038593826 cites W2086863910 @default.
• W2038593826 cites W2091088809 @default.
• W2038593826 cites W2093274300 @default.
• W2038593826 cites W2094134651 @default.
• W2038593826 cites W2107867628 @default.
• W2038593826 cites W2116893493 @default.
• W2038593826 cites W2118770576 @default.
• W2038593826 cites W2119714841 @default.
• W2038593826 cites W2123517430 @default.
• W2038593826 cites W2123636362 @default.
• W2038593826 cites W2132444666 @default.
• W2038593826 cites W2136031842 @default.
• W2038593826 cites W2138595651 @default.
• W2038593826 cites W2146653011 @default.
• W2038593826 cites W2150857753 @default.
• W2038593826 cites W2151772290 @default.
• W2038593826 cites W2154099072 @default.
• W2038593826 cites W2159472149 @default.
• W2038593826 cites W2160143885 @default.
• W2038593826 cites W2161568304 @default.
• W2038593826 cites W2162421322 @default.
• W2038593826 cites W2169839077 @default.
• W2038593826 cites W2171769711 @default.
• W2038593826 cites W4238879677 @default.
• W2038593826 cites W4297067014 @default.
• W2038593826 doi "https://doi.org/10.1016/j.biopsych.2012.10.032" @default.
• W2038593826 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3615042" @default.
• W2038593826 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23273721" @default.
• W2038593826 hasPublicationYear "2013" @default.
• W2038593826 type Work @default.
• W2038593826 sameAs 2038593826 @default.
• W2038593826 citedByCount "47" @default.
• W2038593826 countsByYear W20385938262013 @default.
• W2038593826 countsByYear W20385938262014 @default.
• W2038593826 countsByYear W20385938262015 @default.
• W2038593826 countsByYear W20385938262016 @default.
• W2038593826 countsByYear W20385938262017 @default.
• W2038593826 countsByYear W20385938262018 @default.
• W2038593826 countsByYear W20385938262019 @default.
• W2038593826 countsByYear W20385938262020 @default.
• W2038593826 countsByYear W20385938262021 @default.
• W2038593826 countsByYear W20385938262022 @default.
• W2038593826 countsByYear W20385938262023 @default.
• W2038593826 crossrefType "journal-article" @default.
• W2038593826 hasAuthorship W2038593826A5003815693 @default.
• W2038593826 hasAuthorship W2038593826A5006125403 @default.
• W2038593826 hasAuthorship W2038593826A5017827035 @default.
• W2038593826 hasAuthorship W2038593826A5020143742 @default.
• W2038593826 hasAuthorship W2038593826A5024844325 @default.
• W2038593826 hasAuthorship W2038593826A5024948156 @default.
• W2038593826 hasAuthorship W2038593826A5036545204 @default.
• W2038593826 hasAuthorship W2038593826A5040205642 @default.
• W2038593826 hasAuthorship W2038593826A5042105567 @default.

• next